The role of catecholamines in the action of amphetamine and L-DOPA on cerebral energy metabolism.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology*; D007773:Lactates / Q000378:metabolism; D007980:Levodopa / Q000494:pharmacology*; D008293:Malates / Q000378:metabolism; D008297:Male; D010725:Phosphocreatine / Q000378:metabolism; D010868:Pimozide / Q000494:pharmacology*; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013268:Stimulation, Chemical; D013696:Temperature
D006892:Hydroxydopamines; D007773:Lactates; D008293:Malates; D010725:Phosphocreatine; D010868:Pimozide; D007980:Levodopa; D000255:Adenosine Triphosphate; D006003:Glycogen; D000661:Amphetamine; D000242:Cyclic AMP; D005947:Glucose